**Question:** Which of the following is used to treat Laron's dwarfism?

**Core Concept:** Laron's dwarfism is a rare genetic disorder characterized by primary insulin-like growth factor 1 (IGF-1) deficiency. IGF-1 is a key growth factor that stimulates growth and development, and its deficiency leads to short stature and other developmental abnormalities.

**Why the Correct Answer is Right:**
The correct answer, **D:** GHRH (Growth Hormone Releasing Hormone), is used in the treatment of Laron's dwarfism. GHRH stimulates the pituitary gland to produce and release growth hormone (GH). In Laron's dwarfism, there is a deficiency in the action of growth hormone on target tissues, which leads to the low levels of IGF-1. By stimulating the pituitary gland, GHRH helps to increase GH levels and subsequently elevate IGF-1 levels.

**Why Each Wrong Option is Incorrect:**

A. **Option A:** Dexamethasone is a synthetic glucocorticoid used for anti-inflammatory, immunosuppressive, and antipyretic effects. It does not directly address the IGF-1 deficiency in Laron's dwarfism.

B. **Option B:** Thiazide diuretics are used to treat hypertension and edema by inhibiting the reabsorption of sodium and water in the distal convoluted tubule of the nephron. They are unrelated to the treatment of IGF-1 deficiency in Laron's dwarfism.

C. **Option C:** Insulin is a hormone that regulates carbohydrate, fat, and protein synthesis and glucose uptake in cells. Insulin does not address the primary IGF-1 deficiency in Laron's dwarfism.

**Clinical Pearl:** Laron's dwarfism is a rare genetic disorder characterized by primary IGF-1 deficiency. Treatment with GHRH can help increase GH and IGF-1 levels, leading to improvements in growth and development.

**Correct Answer Explanation:**

**D.** GHRH (Growth Hormone Releasing Hormone) is used to treat Laron's dwarfism because it stimulates the pituitary gland to produce and release growth hormone (GH), which in turn increases insulin-like growth factor-1 (IGF-1) levels. IGF-1 is the primary growth hormone responsible for promoting growth and development.

By increasing GH and IGF-1 levels, GHRH therapy helps alleviate the growth failure and developmental abnormalities associated with Laron's dwarfism. It is essential for medical professionals to differentiate between Laron's dwarfism and other forms of short stature (e.g., Turner's syndrome, Cushing's disease, or hypopituitarism) before initiating treatment.

**Why Each Wrong Option is Incorrect:**

**A.** Dexamethasone (Glucocorticoids) is primarily used to treat inflammation, edema, and other inflammatory conditions. It does not target the primary IGF-1 deficiency in Laron's dwarfism.